{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:50:58Z","timestamp":1790855458595,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7610","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,7,7]]},"DOI":"10.1038\/nature18615","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T11:36:11Z","timestamp":1467200171000},"page":"169-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":247,"title":["Toremifene interacts with and destabilizes the Ebola virus glycoprotein"],"prefix":"10.1038","volume":"535","author":[{"given":"Yuguang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Harlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antra","family":"Zeltina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Padilla-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"BFnature18615_CR1","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","volume":"94","author":"A Takada","year":"1997","unstructured":"Takada, A. et al. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl Acad. Sci. USA 94, 14764\u201314769 (1997)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature18615_CR2","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1038\/ncomms8688","volume":"6","author":"M Hacke","year":"2015","unstructured":"Hacke, M. et al. Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol. Nat. Commun. 6, 7688 (2015)","journal-title":"Nat. Commun."},{"issue":"suppl. 3","key":"BFnature18615_CR3","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jir326","volume":"204","author":"P Aleksandrowicz","year":"2011","unstructured":"Aleksandrowicz, P. et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204 (suppl. 3), S957\u2013S967 (2011)","journal-title":"J. Infect. Dis."},{"key":"BFnature18615_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340\u2013343 (2011)","journal-title":"Nature"},{"key":"BFnature18615_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature10380","volume":"477","author":"M C\u00f4t\u00e9","year":"2011","unstructured":"C\u00f4t\u00e9, M. et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344\u2013348 (2011)","journal-title":"Nature"},{"key":"BFnature18615_CR6","doi-asserted-by":"publisher","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","volume":"6","author":"A Nanbo","year":"2010","unstructured":"Nanbo, A. et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6, e1001121 (2010)","journal-title":"PLoS Pathog."},{"key":"BFnature18615_CR7","doi-asserted-by":"publisher","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","volume":"6","author":"MF Saeed","year":"2010","unstructured":"Saeed, M. F., Kolokoltsov, A. A., Albrecht, T. & Davey, R. A. Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6, e1001110 (2010)","journal-title":"PLoS Pathog."},{"key":"BFnature18615_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177\u2013182 (2008)","journal-title":"Nature"},{"key":"BFnature18615_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","volume":"164","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 164, 258\u2013268 (2016)","journal-title":"Cell"},{"key":"BFnature18615_CR10","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nsmb.2150","volume":"18","author":"JM Dias","year":"2011","unstructured":"Dias, J. M. et al. A shared structural solution for neutralizing ebolaviruses. Nat. Struct. Mol. Biol. 18, 1424\u20131427 (2011)","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnature18615_CR11","unstructured":"World Health Organization. Ebola Situation Reports ; http:\/\/www.who.int\/csr\/disease\/ebola\/situation-reports\/en\/ (2016)"},{"key":"BFnature18615_CR12","first-page":"104","volume":"4","author":"V Veljkovic","year":"2015","unstructured":"Veljkovic, V. et al. In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease. F1000Res . 4, 104 (2015)","journal-title":"analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease. F1000Res"},{"key":"BFnature18615_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1021\/acsinfecdis.5b00053","volume":"1","author":"MR Edwards","year":"2015","unstructured":"Edwards, M. R. et al. High-throughput minigenome system for identifying small-molecule inhibitors of Ebola virus replication. ACS Infect. Dis. 1, 380\u2013387 (2015)","journal-title":"ACS Infect. Dis."},{"key":"BFnature18615_CR14","doi-asserted-by":"publisher","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","volume":"5","author":"LM Johansen","year":"2013","unstructured":"Johansen, L. M. et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci. Transl. Med. 5, 190ra79 (2013)","journal-title":"Sci. Transl. Med."},{"key":"BFnature18615_CR15","doi-asserted-by":"publisher","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","volume":"7","author":"LM Johansen","year":"2015","unstructured":"Johansen, L. M. et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 7, 290ra89 (2015)","journal-title":"Sci. Transl. Med."},{"key":"BFnature18615_CR16","first-page":"e84","volume":"3","author":"J Kouznetsova","year":"2014","unstructured":"Kouznetsova, J. et al. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg. Microbes Infect. 3, e84 (2014)","journal-title":"Microbes Infect."},{"key":"BFnature18615_CR17","doi-asserted-by":"publisher","first-page":"e36219","DOI":"10.1371\/journal.pone.0036219","volume":"7","author":"WA Lea","year":"2012","unstructured":"Lea, W. A. & Simeonov, A. Differential scanning fluorometry signatures as indicators of enzyme inhibitor mode of action: case study of glutathione S-transferase. PLoS One 7, e36219 (2012)","journal-title":"PLoS One"},{"key":"BFnature18615_CR18","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1529\/biophysj.108.134973","volume":"95","author":"P Cimmperman","year":"2008","unstructured":"Cimmperman, P. et al. A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys. J. 95, 3222\u20133231 (2008)","journal-title":"Biophys. J."},{"key":"BFnature18615_CR19","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/JVI.01337-15","volume":"89","author":"H Cheng","year":"2015","unstructured":"Cheng, H. et al. Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists. J. Virol. 89, 9932\u20139938 (2015)","journal-title":"J. Virol."},{"key":"BFnature18615_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/JVI.05708-11","volume":"86","author":"M Brecher","year":"2012","unstructured":"Brecher, M. et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J. Virol. 86, 364\u2013372 (2012)","journal-title":"J. Virol."},{"key":"BFnature18615_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/1873-3468.12089","volume":"590","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y., Ren, J., Harlos, K. & Stuart, D. I. Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions. FEBS Lett. 590, 605\u2013612 (2016)","journal-title":"FEBS Lett."},{"key":"BFnature18615_CR22","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","volume":"76","author":"SA Jeffers","year":"2002","unstructured":"Jeffers, S. A., Sanders, D. A. & Sanchez, A. Covalent modifications of the ebola virus glycoprotein. J. Virol. 76, 12463\u201312472 (2002)","journal-title":"J. Virol."},{"key":"BFnature18615_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1097-2765(00)80159-8","volume":"2","author":"W Weissenhorn","year":"1998","unstructured":"Weissenhorn, W., Carf\u00ed, A., Lee, K. H., Skehel, J. J. & Wiley, D. C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2, 605\u2013616 (1998)","journal-title":"Mol. Cell"},{"key":"BFnature18615_CR24","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.1104760108","volume":"108","author":"SM Gregory","year":"2011","unstructured":"Gregory, S. M. et al. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc. Natl Acad. Sci. USA 108, 11211\u201311216 (2011)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature18615_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","volume":"164","author":"AI Flyak","year":"2016","unstructured":"Flyak, A. I. et al. Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection. Cell 164, 392\u2013405 (2016)","journal-title":"Cell"},{"key":"BFnature18615_CR26","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643\u20131645 (2005)","journal-title":"Science"},{"key":"BFnature18615_CR27","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1128\/JVI.01956-08","volume":"83","author":"D Dube","year":"2009","unstructured":"Dube, D. et al. The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 83, 2883\u20132891 (2009)","journal-title":"J. Virol."},{"key":"BFnature18615_CR28","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1128\/JVI.02151-09","volume":"84","author":"CL Hood","year":"2010","unstructured":"Hood, C. L. et al. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity. J. Virol. 84, 2972\u20132982 (2010)","journal-title":"J. Virol."},{"key":"BFnature18615_CR29","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","volume":"80","author":"K Schornberg","year":"2006","unstructured":"Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174\u20134178 (2006)","journal-title":"J. Virol."},{"key":"BFnature18615_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T Hashiguchi","year":"2015","unstructured":"Hashiguchi, T. et al. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160, 904\u2013912 (2015)","journal-title":"Cell"},{"key":"BFnature18615_CR31","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1038\/ncomms5321","volume":"5","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y., Ren, J., Padilla-Parra, S., Fry, E. E. & Stuart, D. I. Lysosome sorting of \u03b2-glucocerebrosidase by LIMP-2 is targeted by the mannose 6-phosphate receptor. Nat. Commun. 5, 4321 (2014)","journal-title":"Nat. Commun."},{"key":"BFnature18615_CR32","doi-asserted-by":"publisher","first-page":"e1004048","DOI":"10.1371\/journal.ppat.1004048","volume":"10","author":"TM Desai","year":"2014","unstructured":"Desai, T. M. et al. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 10, e1004048 (2014)","journal-title":"PLoS Pathog."},{"key":"BFnature18615_CR33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nbt745","volume":"20","author":"M Cavrois","year":"2002","unstructured":"Cavrois, M., De Noronha, C. & Greene, W. C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20, 1151\u20131154 (2002)","journal-title":"Nat. Biotechnol."},{"key":"BFnature18615_CR34","doi-asserted-by":"publisher","first-page":"13449","DOI":"10.1038\/srep13449","volume":"5","author":"DM Jones","year":"2015","unstructured":"Jones, D. M. & Padilla-Parra, S. Imaging real-time HIV-1 virion fusion with FRET-based biosensors. Sci. Rep. 5, 13449 (2015)","journal-title":"Sci. Rep."},{"key":"BFnature18615_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1107\/S0907444905007808","volume":"61","author":"TS Walter","year":"2005","unstructured":"Walter, T. S. et al. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr. D 61, 651\u2013657 (2005)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature18615_CR36","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1107\/S0907444913015308","volume":"69","author":"G Winter","year":"2013","unstructured":"Winter, G., Lobley, C. M. & Prince, S. M. Decision making in xia2. Acta Crystallogr. D 69, 1260\u20131273 (2013)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature18615_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1107\/S0907444909042589","volume":"66","author":"A Vagin","year":"2010","unstructured":"Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D 66, 22\u201325 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature18615_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0076-6879(03)74014-2","volume":"374","author":"MD Winn","year":"2003","unstructured":"Winn, M. D., Murshudov, G. N. & Papiz, M. Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374, 300\u2013321 (2003)","journal-title":"Methods Enzymol."},{"key":"BFnature18615_CR39","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature18615_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0022-2836(79)90416-9","volume":"134","author":"DI Stuart","year":"1979","unstructured":"Stuart, D. I., Levine, M., Muirhead, H. & Stammers, D. K. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J. Mol. Biol. 134, 109\u2013142 (1979)","journal-title":"J. Mol. Biol."},{"key":"BFnature18615_CR41","first-page":"U1371","volume":"230","author":"WL DeLano","year":"2005","unstructured":"DeLano, W. L. & Lam, J. W. PyMOL: A communications tool for computational models. Abstr. Pap. Am. Chem. Soc . 230, U1371\u2013U1372 (2005)","journal-title":"Abstr. Pap. Am. Chem. Soc"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature18615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature18615","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature18615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:53:26Z","timestamp":1684432406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature18615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":41,"journal-issue":{"issue":"7610","published-print":{"date-parts":[[2016,7,7]]}},"alternative-id":["BFnature18615"],"URL":"https:\/\/doi.org\/10.1038\/nature18615","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]},"assertion":[{"value":"16 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.I.S., T.A.B. and A.Z. are listed as inventors on the International Patent Application No. PCT\/GB2016\/050321 \u2018Filovirus therapy\u2019.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}